Skip to main content
. 2023 Mar 28;15(7):2021. doi: 10.3390/cancers15072021

Table 2.

Effectiveness of immune checkpoint inhibitor therapy.

Variables All %
Number of patients (%) 102
Best response (%)
Complete response 16 15.7
Partial response 38 37.3
Stable disease 22 21.6
Progressive disease 26 25.5
ORR 54 52.9
DCR 76 74.5

ORR, objective response rate; DCR, disease control rate.